Atlas Trials

T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs

Clinical trial NCT01210664 · COMPLETED

Trial details

NCT number
NCT01210664
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2010-11-01
Primary completion
2016-12-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.